Literature DB >> 24700386

Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation.

Sara R Ulimoen1, Steve Enger, Jon Norseth, Are H Pripp, Michael Abdelnoor, Harald Arnesen, Knut Gjesdal, Arnljot Tveit.   

Abstract

BACKGROUND: Detectable levels of troponins are often found in serum of patients with atrial fibrillation (AF), and recent reports suggest that Tn concentrations are independently related to patient prognosis. HYPOTHESIS: We hypothesized that treatment with common rate-reducing drugs might lower the levels of cardiac troponin T (TnT) in patients with permanent AF. We also wanted to investigate whether the different drugs would impact the Tn levels differently.
METHODS: Sixty patients were included (mean age 71 ± 9 years, 18 women) in this randomized crossover study. All patients had stable, permanent AF without ischemic heart disease or congestive heart failure. Diltiazem 360 mg, verapamil 240 mg, metoprolol 100 mg, and carvedilol 25 mg were administered once daily for 3 weeks, in a randomized sequence. At baseline and on the last day of each treatment period, TnT concentrations were measured at rest and after a maximal exercise test.
RESULTS: TnT was detectable in all patients. In 22% of the patients, TnT concentrations were above the threshold normally used for diagnosing myocardial infarction. All drugs reduced the levels of TnT significantly compared with baseline (P < 0.001 for all), but there were no significant differences between the treatments. Levels of TnT increased significantly in response to exercise testing (P < 0.001 for all).
CONCLUSIONS: Elevated TnT was demonstrated in a large proportion of stable patients with permanent AF without ischemic heart disease. A moderate reduction of heart rate by the study drugs was associated with a significant reduction in levels of TnT.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700386      PMCID: PMC6649449          DOI: 10.1002/clc.22281

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  6 in total

Review 1.  The Significance Of Troponin Elevation In Atrial Fibrillation.

Authors:  Juan Pablo Costabel; Lucrecia María Burgos; Marcelo Trivi
Journal:  J Atr Fibrillation       Date:  2017-04-30

2.  Non-coronary predictors of elevated high-sensitive cardiac troponin T (hs-cTnT) levels in an unselected emergency patient cohort.

Authors:  Manfred Berger; Meryem Emir; Tanja Brünnler; Felix Rockmann; Ralf Lehmann
Journal:  Clin Cardiol       Date:  2018-08-16       Impact factor: 2.882

3.  Treatment With Cardiovascular Medications: Prognosis in Patients With Myocardial Injury.

Authors:  Erik Kadesjö; Andreas Roos; Anwar J Siddiqui; Ulrik Sartipy; Martin J Holzmann
Journal:  J Am Heart Assoc       Date:  2020-12-29       Impact factor: 5.501

4.  Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.

Authors:  Anja Wiedswang Horjen; Sara Reinvik Ulimoen; Steve Enger; Jon Norseth; Ingebjørg Seljeflot; Harald Arnesen; Arnljot Tveit
Journal:  BMC Cardiovasc Disord       Date:  2016-05-04       Impact factor: 2.298

5.  Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation.

Authors:  Pascal B Meyre; Stefanie Aeschbacher; Steffen Blum; Gian Voellmin; Peter M Kastner; Elisa Hennings; Beat A Kaufmann; Michael Kühne; Stefan Osswald; David Conen
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

6.  Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health Informatics Collaborative TROP-AF study).

Authors:  Amit Kaura; Ahran D Arnold; Vasileios Panoulas; Benjamin Glampson; Jim Davies; Abdulrahim Mulla; Kerrie Woods; Joe Omigie; Anoop D Shah; Keith M Channon; Jonathan N Weber; Mark R Thursz; Paul Elliott; Harry Hemingway; Bryan Williams; Folkert W Asselbergs; Michael O'Sullivan; Graham M Lord; Narbeh Melikian; David C Lefroy; Darrel P Francis; Ajay M Shah; Rajesh Kharbanda; Divaka Perera; Riyaz S Patel; Jamil Mayet
Journal:  J Am Heart Assoc       Date:  2020-03-26       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.